Last updated: 2026-10-11 17:16:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Forte Biosciences, Inc. (FBRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Forte Biosciences, Inc. (FBRX) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, FBRX traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Forte Biosciences, Inc. (FBRX) moved from $76.86 to $76.99, representing a gain of 0.17% ($0.13).
The stock traded between $76.82 and $77.00 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 2.34 million shares, up versus the previous seven-day period, indicating higher trading activity.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 23 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Forte Biosciences, Inc. (FBRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.